Commercial Success for First Probiotic for Stress Management

13 Dec 2011 --- In France, Urgo markets the formula as ImmunoStim Stress, as part of its new ImmunoStim full range of probiotics, sold through pharmacies. French pharmacists were appealed by the innovation and scientific background behind this product.

Dec 13 2011 --- Institut Rosell-Lallemand’s Probio’Stick (a combination of Lactobacillus Rosell-52 and Bifidobacterium Rosell-175), the first probiotic solution proven to alleviate both physical and psychological symptoms of stress, has recently expanded into new territories with launches in France and Mexico by the company’s local partners Urgo and medix, respectively.

In France, Urgo markets the formula as ImmunoStim Stress, as part of its new ImmunoStim full range of probiotics, sold through pharmacies. French pharmacists were appealed by the innovation and scientific background behind this product.

In Mexico, Probio’Stick is sold under trade mark Senex 3. Medix organized a launch tour early November, gathering several hundreds gastroenterologists and internists.

Isabelle Champié, International Marketing Director for Institut Rosell-Lallemand comments: “We are very proud of the success of our Probio’Stick formula among high profile international partners in the healthcare sector. This success is for us the best recognition of our commitment to the scientific & clinical documentation of our products. This formula is the first probiotic preparation to be backed by two clinical studies showing its efficacy on both physical and psychological symptoms of stress and anxiety.” She added: “If stress-relief and well-being are today identified as promising markets, the number of serious, safe and well-documented products is still limited, especially when it comes to psychological benefits, such as those observed with Probio’Stick applying the type of psychological tests traditionally used for drugs.”

Since Institut Rosell-Lallemand developed Probio’Stick formula in 2005, it has been launched in several key markets around the world: China (with Minsheng pharmaceutical), Canada (distributed by Jamieson Laboratories), Scandinavia (with Baltex) and Portugal (with Prisfar).

A first clinical trial, published in 2008 (Diop et al.) showed the preparation’s efficacy to alleviate gastro-intestinal symptoms linked to stress in chronic stress sufferers, mainly abdominal pain and nausea. In 2010, a new study was published by Messaoudi et al., looking into the probiotics’ effects on psychological symptoms this time, using a range of psychological tests as well as a biomarker for stress and anxiety. This unique study concluded to the probiotic’s beneficial effects on general signs of anxiety and depression and to improve one’s ability to cope with the stress of everyday’s life events. These significant effects are supported by several pre-clinical studies.

Probio’Stick combines a patented micro-encapsulation technology — Probiocap — with a blend of two well-documented Institut Rosell-Lallemand strains: Lactobacillus Rosell-52 and Bifidobacterium Rosell-175. Thanks to this protective micro-encapsulation technology, the probiotic resists gastric acids. Packaged in single-dose sticks of flavored powder that dissolves quickly in the mouth, Probio’Stick can be taken anywhere without water and at any time of the day, even between meals when gastric pH is at its lowest. It is recommended to reduce the gastro intestinal symptoms due to stress.

Diop L., Guillou S., Durand H. : Probiotic food supplement reduces stress-induced gastrointestinal symptoms in volunteers: A double-blind, placebo-controlled, randomized trial.  Nutrition Research Volume 28, Issue 1, January 2008. Pages 1-5.

Messaoudi M., Lalonde R., Violle N., Javelot H., Desor D, Nejdi A., Bisson J.-F., Rougeot C., Pichelin M., Cazaubiel M. And Cazaubiel J.-M.: Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and humans. Br J Nutr. 2010 Oct 26:1-9.

Related Articles

Nutrition & Health News

BioGaia probiotic found to reduce bone loss in older women

20 Nov 2017 --- Supplementation of the BioGaia probiotic strain Lactobacillus reuteri ATCC PTA 6475 decreased bone loss compared to placebo in 90 older women. This is according to the results of a randomized, double-blind, placebo-controlled study at the University of Gothenburg.

Nutrition & Health News

Gut bacteria sensitive to salt, linked to MS and hypertension: study

20 Nov 2017 --- Common salt reduces the number of certain lactic acid bacteria in the gut of mice and humans. This is according to a study published in the journal Nature by Berlin's Max Delbrück Center and Charité, which further notes an impact on immune cells that are partly responsible for autoimmune diseases like multiple sclerosis (MS) and hypertension. Probiotics were also found to ameliorate the symptoms of disease in mice.

Nutrition & Health News

Weight management – Keeping the kilos off (Part 3): Trends, innovation and strong opinions

17 Oct 2017 --- Weight management is a hot topic in the nutrition industry, and NutritionInsight has solicited the views of medical professionals and industry insiders on the next steps to take. Today, in the final part of a special report, we share the trends in the industry, some new R&D and expert opinions in the space in general.

Nutrition & Health News

Evolva to work with Northumbria University for studies on health benefits of resveratrol

17 Nov 2017 --- Evolva is entering a collaboration with Northumbria University’s Brain, Performance and Nutrition Research Centre in the UK for a series of studies on Veri-te resveratrol. The collaboration will include human intervention studies that will assess the inter-relationships between obesity, gut health (through microbiota populations), systemic inflammation, cognitive function, cerebral blood flow and peripheral blood flow and how all of these factors can be modulated by resveratrol dietary supplementation.

Nutrition & Health News

Weight management – Keeping the kilos off (Part 2): Challenges and delivery methods

15 Nov 2017 --- Weight management is a hot topic in the nutrition industry, and NutritionInsight has been asking for the views of medical professionals and industry insiders on the next steps to take. Today in the second part of a special report, we look at the challenges currently being presented to the industry and delivery methods being used for weight management products.

More Articles
URL : http://www.nutritioninsight.com:80/news/Commercial-Success-for-First-Probiotic-for-Stress-Management.html